An innovative approach to overcome the risk factors and stem the failure of drugs which are often developed on a trial and error basis, the concept of personalised medicine comes with its own share of benefits and challenges.
Leading research-based Indian pharmaceutical companies spend less than 10 per cent of their sales...
Biotech consolidation through acquisition was the primary trend in 2007 for the big pharma and the global...
Personalised medicine breaks the cycle of trial and error medicine and helps ineffectiveness rates of medicines...
Personalised medicine, in which sophisticated diagnostics guide drug choice, dosing, and patient appropriateness...
The development of optimised process for freeze-dried product is described. New available analytical tools...
Making the best use of the equipment and reducing costs are two of the key challenges among many that the...
With the advancement of our understanding of pathobiology of many cancers, many biologically targeted agents...
Techniques such as electroencephalography and evoked potential are useful tools for translation of preclinical...
n life sciences, traditional supply chains were designed from the inside-out perspective.
Drawing parallels with the semiconductor industry, the authors argue that biopharmaceutical firms...
Data mining has always been important to our industry. Having the ability to mine across the entire product...
IT can play a key role in cutting down the costs of production and helping biopharmaceutical companies maintain...
The Editorial Advisory Board of Pharma Focus Asia comprises of industry thought leaders with wide-ranging experience, expertise and significant contributions to the pharmaceutical industry.
Pharma Focus Asia, published quarterly, is the leading pharma magazine in print and digital versions covering important issues and trends shaping the future of the Asian pharmaceutical industry.
Pharma Focus Asia is the only pharma magazine with Asian focus that reaches to the people who matter-C-level and senior executives in the pharma industry and key decision makers in charge of spending. Delivering reliable and accurate coverage of the pharma industry's progress, this pharma magazine helps its readers make informed decisions to stay ahead of the competition.
The best-in-class pharmaceutical magazine, Pharma Focus Asia provides cutting-edge content presented intelligibly under Strategy, Research & Development, Pharmaceutical Manufacturing, Clinical Trials and Information Technology sections.
During the last few years, pharmaceutical companies have shifted their focus in Pharmacovigilance...
Peter Ehrenheim, President & CEO, Life Sciences, GE Healthcare, UK
This volume will provide researchers with recent information on bioactivation reactions of drugs and toxicants...
We postulated that pharmacological targeting of putative stromal support functions, in particular those...
Unigene plans to build pharmaceutical manufacturing plant and R&D centres in China.
Jiangsu Stem Cell Storage and processing facility is to be constructed in Jiangsu province, China.
Researchers at the Massachusetts Institute of Technology have come up with the first fully synthetic...
Researchers at the University of Leeds have come up with a technology that could help the pharmaceutical industry...
A Report by PricewaterhouseCoopers
Pharma is at a pivotal point in its evolution, particularly in relation to R&D.
Pharma's New Worldview
To date, research and development (R&D) within the pharmaceutical industry has been dominated by a developed-market perspective.

29 Jun, 2009
Sinovac receives revised approval for Panflu
...
24 Jun, 2009
Merck Serono Launches RebiSmart(TM) for Multiple Sclerosis Treatment
...
24 Jun, 2009
Watson Laboratories Receives FDA Approval for Levonorgestrel
...

29 Jun, 2009
Mylan Announces Strategic Collaboration with Biocon to Enter the Globa
...
29 Jun, 2009
Cordex Completes Production of ATPace(TM) Clinical Trial Material
...
24 Jun, 2009
TriLink BioTechnologies, Inc. Announces Sales and License Agreement Wi
...

Jul 18 - Jul 20 2009
2nd Annual World Summit of Antivirals...
Jul 18 - Jul 25 2009
2nd Annual World Summit of Antivirals...
Sep 13 - Sep 15 2009
ISPE Australia Conference 2009...
I have been very impressed with the quality and timeliness of the articles. Each of...
David R. Webb
Vice President, Research
Signal Pharmaceuticals
LLC, A wholly owned
subsidiary of CELGENE, USA
The magazine looked great and there were excellent articles of huge interest.
Dr Iman El-Hariry
Group Director
Oncology MDC, Europe
GlaxoSmithKline, UK